nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—asthma	0.249	0.678	CbGaD
Pomalidomide—PTGS2—asthma	0.118	0.322	CbGaD
Pomalidomide—ABCB1—Fluticasone furoate—asthma	0.025	0.0624	CbGbCtD
Pomalidomide—PTGS2—Triamcinolone—asthma	0.0228	0.0571	CbGbCtD
Pomalidomide—ABCB1—Indacaterol—asthma	0.0204	0.0509	CbGbCtD
Pomalidomide—PTGS2—Betamethasone—asthma	0.0196	0.049	CbGbCtD
Pomalidomide—CYP1A2—Zileuton—asthma	0.0193	0.0482	CbGbCtD
Pomalidomide—CYP1A2—Zafirlukast—asthma	0.017	0.0425	CbGbCtD
Pomalidomide—CYP3A4—Fluticasone furoate—asthma	0.015	0.0374	CbGbCtD
Pomalidomide—CYP1A2—Aminophylline—asthma	0.0139	0.0349	CbGbCtD
Pomalidomide—CYP3A4—Budesonide—asthma	0.0133	0.0333	CbGbCtD
Pomalidomide—CYP1A2—Theophylline—asthma	0.0131	0.0328	CbGbCtD
Pomalidomide—CYP3A4—Ciclesonide—asthma	0.0122	0.0305	CbGbCtD
Pomalidomide—CYP3A4—Indacaterol—asthma	0.0122	0.0305	CbGbCtD
Pomalidomide—PTGS2—Dexamethasone—asthma	0.0114	0.0285	CbGbCtD
Pomalidomide—CYP3A4—Flunisolide—asthma	0.0113	0.0284	CbGbCtD
Pomalidomide—CYP3A4—Salbutamol—asthma	0.0113	0.0284	CbGbCtD
Pomalidomide—CYP3A4—Salmeterol—asthma	0.0113	0.0284	CbGbCtD
Pomalidomide—ABCB1—Loratadine—asthma	0.0109	0.0272	CbGbCtD
Pomalidomide—CYP3A4—Zileuton—asthma	0.0101	0.0253	CbGbCtD
Pomalidomide—CYP3A4—Ipratropium bromide—asthma	0.0101	0.0253	CbGbCtD
Pomalidomide—ABCB1—Methylprednisolone—asthma	0.00994	0.0249	CbGbCtD
Pomalidomide—CYP3A4—Fluticasone Propionate—asthma	0.00964	0.0241	CbGbCtD
Pomalidomide—CYP3A4—Zafirlukast—asthma	0.00889	0.0223	CbGbCtD
Pomalidomide—CYP3A4—Tiotropium—asthma	0.00766	0.0192	CbGbCtD
Pomalidomide—CYP3A4—Aminophylline—asthma	0.0073	0.0183	CbGbCtD
Pomalidomide—CYP3A4—Theophylline—asthma	0.00687	0.0172	CbGbCtD
Pomalidomide—CYP3A4—Loratadine—asthma	0.00651	0.0163	CbGbCtD
Pomalidomide—CYP3A4—Montelukast—asthma	0.00651	0.0163	CbGbCtD
Pomalidomide—ABCB1—Betamethasone—asthma	0.00646	0.0162	CbGbCtD
Pomalidomide—ABCB1—Prednisolone—asthma	0.00638	0.0159	CbGbCtD
Pomalidomide—ABCB1—Hydrocortisone—asthma	0.00604	0.0151	CbGbCtD
Pomalidomide—ABCB1—Prednisone—asthma	0.00602	0.0151	CbGbCtD
Pomalidomide—CYP3A4—Methylprednisolone—asthma	0.00595	0.0149	CbGbCtD
Pomalidomide—CYP3A4—Triamcinolone—asthma	0.00451	0.0113	CbGbCtD
Pomalidomide—CYP3A4—Betamethasone—asthma	0.00387	0.00969	CbGbCtD
Pomalidomide—CYP3A4—Prednisolone—asthma	0.00382	0.00956	CbGbCtD
Pomalidomide—ABCB1—Dexamethasone—asthma	0.00376	0.0094	CbGbCtD
Pomalidomide—CYP3A4—Hydrocortisone—asthma	0.00362	0.00906	CbGbCtD
Pomalidomide—CYP3A4—Prednisone—asthma	0.00361	0.00902	CbGbCtD
Pomalidomide—CYP3A4—Dexamethasone—asthma	0.00225	0.00563	CbGbCtD
Pomalidomide—CRBN—respiratory system—asthma	0.0012	0.128	CbGeAlD
Pomalidomide—CRBN—adrenal cortex—asthma	0.00101	0.107	CbGeAlD
Pomalidomide—CRBN—bronchus—asthma	0.000988	0.105	CbGeAlD
Pomalidomide—Thalidomide—TNF—asthma	0.00097	0.441	CrCbGaD
Pomalidomide—CRBN—trachea—asthma	0.000887	0.0944	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—asthma	0.000769	0.35	CrCbGaD
Pomalidomide—CRBN—adrenal gland—asthma	0.000727	0.0774	CbGeAlD
Pomalidomide—CRBN—lung—asthma	0.000637	0.0678	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—asthma	0.000461	0.209	CrCbGaD
Pomalidomide—CYP1A2—respiratory system—asthma	0.000395	0.042	CbGeAlD
Pomalidomide—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000356	0.111	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000349	0.109	CbGdCrCtD
Pomalidomide—PTGS2—respiratory system—asthma	0.000327	0.0348	CbGeAlD
Pomalidomide—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.000326	0.101	CbGdCrCtD
Pomalidomide—PTGS2—adrenal cortex—asthma	0.000274	0.0292	CbGeAlD
Pomalidomide—PTGS2—epithelium—asthma	0.000273	0.0291	CbGeAlD
Pomalidomide—PTGS2—bronchus—asthma	0.000269	0.0286	CbGeAlD
Pomalidomide—PTGS2—smooth muscle tissue—asthma	0.000263	0.028	CbGeAlD
Pomalidomide—PTGS2—cardiovascular system—asthma	0.00025	0.0266	CbGeAlD
Pomalidomide—PTGS2—trachea—asthma	0.000241	0.0257	CbGeAlD
Pomalidomide—PTGS2—Fluocinonide—Beclomethasone—asthma	0.000239	0.0745	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Budesonide—asthma	0.000229	0.0714	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Flunisolide—asthma	0.000226	0.0705	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000211	0.0656	CbGdCrCtD
Pomalidomide—CYP1A2—lung—asthma	0.000209	0.0223	CbGeAlD
Pomalidomide—ABCB1—respiratory system—asthma	0.000202	0.0215	CbGeAlD
Pomalidomide—PTGS2—adrenal gland—asthma	0.000198	0.0211	CbGeAlD
Pomalidomide—PTGS2—Fluocinonide—Mometasone—asthma	0.000186	0.0577	CbGdCrCtD
Pomalidomide—PTGS2—lung—asthma	0.000174	0.0185	CbGeAlD
Pomalidomide—ABCB1—adrenal cortex—asthma	0.00017	0.0181	CbGeAlD
Pomalidomide—ABCB1—epithelium—asthma	0.000169	0.018	CbGeAlD
Pomalidomide—ABCB1—cardiovascular system—asthma	0.000155	0.0165	CbGeAlD
Pomalidomide—ABCB1—trachea—asthma	0.000149	0.0159	CbGeAlD
Pomalidomide—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	0.000144	0.0449	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Flunisolide—asthma	0.000137	0.0425	CbGdCrCtD
Pomalidomide—ABCB1—adrenal gland—asthma	0.000122	0.013	CbGeAlD
Pomalidomide—PTGS2—Fluticasone Propionate—Mometasone—asthma	0.000112	0.0348	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Methylprednisolone—asthma	0.000111	0.0345	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Dexamethasone—asthma	0.000109	0.0339	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Betamethasone—asthma	0.000109	0.0339	CbGdCrCtD
Pomalidomide—ABCB1—lung—asthma	0.000107	0.0114	CbGeAlD
Pomalidomide—PTGS2—Fluocinonide—Triamcinolone—asthma	0.000107	0.0332	CbGdCrCtD
Pomalidomide—Body temperature increased—Salbutamol—asthma	7.39e-05	0.000507	CcSEcCtD
Pomalidomide—Nausea—Loratadine—asthma	7.3e-05	0.0005	CcSEcCtD
Pomalidomide—Hypersensitivity—Formoterol—asthma	7.29e-05	0.0005	CcSEcCtD
Pomalidomide—Hypersensitivity—Arformoterol—asthma	7.29e-05	0.0005	CcSEcCtD
Pomalidomide—Epistaxis—Triamcinolone—asthma	7.29e-05	0.0005	CcSEcCtD
Pomalidomide—Nausea—Tiotropium—asthma	7.28e-05	0.0005	CcSEcCtD
Pomalidomide—Dry skin—Prednisone—asthma	7.26e-05	0.000498	CcSEcCtD
Pomalidomide—Connective tissue disorder—Hydrocortisone—asthma	7.24e-05	0.000497	CcSEcCtD
Pomalidomide—Vomiting—Flunisolide—asthma	7.23e-05	0.000496	CcSEcCtD
Pomalidomide—Diarrhoea—Mometasone—asthma	7.21e-05	0.000495	CcSEcCtD
Pomalidomide—Hypokalaemia—Prednisone—asthma	7.21e-05	0.000495	CcSEcCtD
Pomalidomide—Rash—Flunisolide—asthma	7.17e-05	0.000492	CcSEcCtD
Pomalidomide—Dermatitis—Flunisolide—asthma	7.16e-05	0.000491	CcSEcCtD
Pomalidomide—Weight increased—Betamethasone—asthma	7.16e-05	0.000491	CcSEcCtD
Pomalidomide—Weight increased—Dexamethasone—asthma	7.16e-05	0.000491	CcSEcCtD
Pomalidomide—Body temperature increased—Budesonide—asthma	7.16e-05	0.000491	CcSEcCtD
Pomalidomide—Hypersensitivity—Montelukast—asthma	7.14e-05	0.00049	CcSEcCtD
Pomalidomide—Headache—Flunisolide—asthma	7.12e-05	0.000488	CcSEcCtD
Pomalidomide—Weight decreased—Dexamethasone—asthma	7.12e-05	0.000488	CcSEcCtD
Pomalidomide—Weight decreased—Betamethasone—asthma	7.12e-05	0.000488	CcSEcCtD
Pomalidomide—Asthenia—Arformoterol—asthma	7.1e-05	0.000487	CcSEcCtD
Pomalidomide—Asthenia—Formoterol—asthma	7.1e-05	0.000487	CcSEcCtD
Pomalidomide—Hyperglycaemia—Dexamethasone—asthma	7.09e-05	0.000487	CcSEcCtD
Pomalidomide—Hyperglycaemia—Betamethasone—asthma	7.09e-05	0.000487	CcSEcCtD
Pomalidomide—Pruritus—Formoterol—asthma	7e-05	0.00048	CcSEcCtD
Pomalidomide—Pruritus—Arformoterol—asthma	7e-05	0.00048	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Prednisone—asthma	6.99e-05	0.000479	CcSEcCtD
Pomalidomide—Muscular weakness—Prednisone—asthma	6.99e-05	0.000479	CcSEcCtD
Pomalidomide—Asthenia—Montelukast—asthma	6.96e-05	0.000477	CcSEcCtD
Pomalidomide—Hypersensitivity—Salbutamol—asthma	6.89e-05	0.000472	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Dexamethasone—asthma	6.87e-05	0.000471	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Betamethasone—asthma	6.87e-05	0.000471	CcSEcCtD
Pomalidomide—Pruritus—Montelukast—asthma	6.86e-05	0.00047	CcSEcCtD
Pomalidomide—Connective tissue disorder—Methylprednisolone—asthma	6.8e-05	0.000467	CcSEcCtD
Pomalidomide—Diarrhoea—Arformoterol—asthma	6.77e-05	0.000464	CcSEcCtD
Pomalidomide—Diarrhoea—Formoterol—asthma	6.77e-05	0.000464	CcSEcCtD
Pomalidomide—Nausea—Flunisolide—asthma	6.75e-05	0.000463	CcSEcCtD
Pomalidomide—Asthenia—Salbutamol—asthma	6.7e-05	0.00046	CcSEcCtD
Pomalidomide—Vomiting—Mometasone—asthma	6.7e-05	0.00046	CcSEcCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	6.69e-05	0.0208	CbGdCrCtD
Pomalidomide—Hypersensitivity—Budesonide—asthma	6.67e-05	0.000457	CcSEcCtD
Pomalidomide—Rash—Mometasone—asthma	6.65e-05	0.000456	CcSEcCtD
Pomalidomide—Dermatitis—Mometasone—asthma	6.64e-05	0.000455	CcSEcCtD
Pomalidomide—Diarrhoea—Montelukast—asthma	6.63e-05	0.000455	CcSEcCtD
Pomalidomide—Pruritus—Salbutamol—asthma	6.61e-05	0.000453	CcSEcCtD
Pomalidomide—Headache—Mometasone—asthma	6.6e-05	0.000453	CcSEcCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Betamethasone—asthma	6.58e-05	0.0205	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	6.58e-05	0.0205	CbGdCrCtD
Pomalidomide—Dizziness—Arformoterol—asthma	6.54e-05	0.000449	CcSEcCtD
Pomalidomide—Dizziness—Formoterol—asthma	6.54e-05	0.000449	CcSEcCtD
Pomalidomide—Asthenia—Budesonide—asthma	6.49e-05	0.000445	CcSEcCtD
Pomalidomide—Mental disorder—Hydrocortisone—asthma	6.46e-05	0.000443	CcSEcCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	6.43e-05	0.02	CbGdCrCtD
Pomalidomide—Cardiac disorder—Methylprednisolone—asthma	6.42e-05	0.000441	CcSEcCtD
Pomalidomide—Malnutrition—Hydrocortisone—asthma	6.41e-05	0.00044	CcSEcCtD
Pomalidomide—Dizziness—Montelukast—asthma	6.41e-05	0.00044	CcSEcCtD
Pomalidomide—Neutropenia—Prednisone—asthma	6.4e-05	0.000439	CcSEcCtD
Pomalidomide—Pruritus—Budesonide—asthma	6.4e-05	0.000439	CcSEcCtD
Pomalidomide—Diarrhoea—Salbutamol—asthma	6.39e-05	0.000439	CcSEcCtD
Pomalidomide—Vomiting—Arformoterol—asthma	6.29e-05	0.000432	CcSEcCtD
Pomalidomide—Vomiting—Formoterol—asthma	6.29e-05	0.000432	CcSEcCtD
Pomalidomide—Angiopathy—Methylprednisolone—asthma	6.28e-05	0.000431	CcSEcCtD
Pomalidomide—Nausea—Mometasone—asthma	6.26e-05	0.00043	CcSEcCtD
Pomalidomide—Rash—Formoterol—asthma	6.24e-05	0.000428	CcSEcCtD
Pomalidomide—Rash—Arformoterol—asthma	6.24e-05	0.000428	CcSEcCtD
Pomalidomide—Mediastinal disorder—Methylprednisolone—asthma	6.24e-05	0.000428	CcSEcCtD
Pomalidomide—Dermatitis—Arformoterol—asthma	6.23e-05	0.000428	CcSEcCtD
Pomalidomide—Dermatitis—Formoterol—asthma	6.23e-05	0.000428	CcSEcCtD
Pomalidomide—Weight increased—Prednisone—asthma	6.23e-05	0.000427	CcSEcCtD
Pomalidomide—Headache—Formoterol—asthma	6.2e-05	0.000425	CcSEcCtD
Pomalidomide—Headache—Arformoterol—asthma	6.2e-05	0.000425	CcSEcCtD
Pomalidomide—Weight decreased—Prednisone—asthma	6.2e-05	0.000425	CcSEcCtD
Pomalidomide—Diarrhoea—Budesonide—asthma	6.19e-05	0.000425	CcSEcCtD
Pomalidomide—Dizziness—Salbutamol—asthma	6.18e-05	0.000424	CcSEcCtD
Pomalidomide—Hyperglycaemia—Prednisone—asthma	6.18e-05	0.000424	CcSEcCtD
Pomalidomide—Vomiting—Montelukast—asthma	6.16e-05	0.000423	CcSEcCtD
Pomalidomide—Rash—Montelukast—asthma	6.11e-05	0.000419	CcSEcCtD
Pomalidomide—Dermatitis—Montelukast—asthma	6.11e-05	0.000419	CcSEcCtD
Pomalidomide—Headache—Montelukast—asthma	6.07e-05	0.000416	CcSEcCtD
Pomalidomide—Mental disorder—Methylprednisolone—asthma	6.06e-05	0.000416	CcSEcCtD
Pomalidomide—Malnutrition—Methylprednisolone—asthma	6.03e-05	0.000413	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Prednisone—asthma	5.99e-05	0.000411	CcSEcCtD
Pomalidomide—Dizziness—Budesonide—asthma	5.99e-05	0.000411	CcSEcCtD
Pomalidomide—Vomiting—Salbutamol—asthma	5.94e-05	0.000408	CcSEcCtD
Pomalidomide—Vertigo—Prednisolone—asthma	5.9e-05	0.000405	CcSEcCtD
Pomalidomide—Rash—Salbutamol—asthma	5.89e-05	0.000404	CcSEcCtD
Pomalidomide—Dermatitis—Salbutamol—asthma	5.89e-05	0.000404	CcSEcCtD
Pomalidomide—Nausea—Arformoterol—asthma	5.88e-05	0.000403	CcSEcCtD
Pomalidomide—Nausea—Formoterol—asthma	5.88e-05	0.000403	CcSEcCtD
Pomalidomide—Headache—Salbutamol—asthma	5.85e-05	0.000402	CcSEcCtD
Pomalidomide—Back pain—Triamcinolone—asthma	5.84e-05	0.000401	CcSEcCtD
Pomalidomide—Vertigo—Hydrocortisone—asthma	5.76e-05	0.000395	CcSEcCtD
Pomalidomide—Nausea—Montelukast—asthma	5.76e-05	0.000395	CcSEcCtD
Pomalidomide—Vomiting—Budesonide—asthma	5.76e-05	0.000395	CcSEcCtD
Pomalidomide—Angiopathy—Betamethasone—asthma	5.71e-05	0.000392	CcSEcCtD
Pomalidomide—Angiopathy—Dexamethasone—asthma	5.71e-05	0.000392	CcSEcCtD
Pomalidomide—Rash—Budesonide—asthma	5.71e-05	0.000391	CcSEcCtD
Pomalidomide—Dermatitis—Budesonide—asthma	5.7e-05	0.000391	CcSEcCtD
Pomalidomide—Headache—Budesonide—asthma	5.67e-05	0.000389	CcSEcCtD
Pomalidomide—Nausea—Salbutamol—asthma	5.55e-05	0.000381	CcSEcCtD
Pomalidomide—Anxiety—Hydrocortisone—asthma	5.44e-05	0.000373	CcSEcCtD
Pomalidomide—Vertigo—Triamcinolone—asthma	5.43e-05	0.000372	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.42e-05	0.000372	CcSEcCtD
Pomalidomide—Vertigo—Methylprednisolone—asthma	5.41e-05	0.000371	CcSEcCtD
Pomalidomide—Connective tissue disorder—Prednisone—asthma	5.39e-05	0.000369	CcSEcCtD
Pomalidomide—Nausea—Budesonide—asthma	5.38e-05	0.000369	CcSEcCtD
Pomalidomide—Cough—Triamcinolone—asthma	5.27e-05	0.000361	CcSEcCtD
Pomalidomide—Infection—Hydrocortisone—asthma	5.2e-05	0.000357	CcSEcCtD
Pomalidomide—Hyperhidrosis—Prednisolone—asthma	5.18e-05	0.000355	CcSEcCtD
Pomalidomide—Nervous system disorder—Hydrocortisone—asthma	5.13e-05	0.000352	CcSEcCtD
Pomalidomide—Arthralgia—Methylprednisolone—asthma	5.13e-05	0.000352	CcSEcCtD
Pomalidomide—Anxiety—Methylprednisolone—asthma	5.11e-05	0.000351	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.09e-05	0.000349	CcSEcCtD
Pomalidomide—Skin disorder—Hydrocortisone—asthma	5.08e-05	0.000349	CcSEcCtD
Pomalidomide—Hyperhidrosis—Hydrocortisone—asthma	5.06e-05	0.000347	CcSEcCtD
Pomalidomide—Angiopathy—Prednisone—asthma	4.97e-05	0.000341	CcSEcCtD
Pomalidomide—Confusional state—Methylprednisolone—asthma	4.96e-05	0.00034	CcSEcCtD
Pomalidomide—Vertigo—Betamethasone—asthma	4.92e-05	0.000338	CcSEcCtD
Pomalidomide—Vertigo—Dexamethasone—asthma	4.92e-05	0.000338	CcSEcCtD
Pomalidomide—Infection—Triamcinolone—asthma	4.9e-05	0.000336	CcSEcCtD
Pomalidomide—Infection—Methylprednisolone—asthma	4.89e-05	0.000335	CcSEcCtD
Pomalidomide—Insomnia—Prednisolone—asthma	4.85e-05	0.000332	CcSEcCtD
Pomalidomide—Nervous system disorder—Methylprednisolone—asthma	4.82e-05	0.000331	CcSEcCtD
Pomalidomide—Mental disorder—Prednisone—asthma	4.8e-05	0.000329	CcSEcCtD
Pomalidomide—Skin disorder—Methylprednisolone—asthma	4.78e-05	0.000328	CcSEcCtD
Pomalidomide—Malnutrition—Prednisone—asthma	4.77e-05	0.000327	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Hydrocortisone—asthma	4.77e-05	0.000327	CcSEcCtD
Pomalidomide—Hyperhidrosis—Triamcinolone—asthma	4.77e-05	0.000327	CcSEcCtD
Pomalidomide—Hyperhidrosis—Methylprednisolone—asthma	4.75e-05	0.000326	CcSEcCtD
Pomalidomide—Insomnia—Hydrocortisone—asthma	4.73e-05	0.000325	CcSEcCtD
Pomalidomide—Anxiety—Betamethasone—asthma	4.65e-05	0.000319	CcSEcCtD
Pomalidomide—Anxiety—Dexamethasone—asthma	4.65e-05	0.000319	CcSEcCtD
Pomalidomide—Pain—Prednisolone—asthma	4.58e-05	0.000314	CcSEcCtD
Pomalidomide—Decreased appetite—Hydrocortisone—asthma	4.55e-05	0.000312	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Hydrocortisone—asthma	4.52e-05	0.00031	CcSEcCtD
Pomalidomide—Fatigue—Hydrocortisone—asthma	4.51e-05	0.00031	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Triamcinolone—asthma	4.49e-05	0.000308	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methylprednisolone—asthma	4.48e-05	0.000307	CcSEcCtD
Pomalidomide—Pain—Hydrocortisone—asthma	4.48e-05	0.000307	CcSEcCtD
Pomalidomide—Insomnia—Triamcinolone—asthma	4.46e-05	0.000306	CcSEcCtD
Pomalidomide—Insomnia—Methylprednisolone—asthma	4.45e-05	0.000305	CcSEcCtD
Pomalidomide—Infection—Dexamethasone—asthma	4.44e-05	0.000305	CcSEcCtD
Pomalidomide—Infection—Betamethasone—asthma	4.44e-05	0.000305	CcSEcCtD
Pomalidomide—Feeling abnormal—Prednisolone—asthma	4.42e-05	0.000303	CcSEcCtD
Pomalidomide—Anaemia—Prednisone—asthma	4.41e-05	0.000303	CcSEcCtD
Pomalidomide—Dyspnoea—Triamcinolone—asthma	4.39e-05	0.000301	CcSEcCtD
Pomalidomide—Nervous system disorder—Betamethasone—asthma	4.39e-05	0.000301	CcSEcCtD
Pomalidomide—Nervous system disorder—Dexamethasone—asthma	4.39e-05	0.000301	CcSEcCtD
Pomalidomide—Thrombocytopenia—Dexamethasone—asthma	4.38e-05	0.0003	CcSEcCtD
Pomalidomide—Thrombocytopenia—Betamethasone—asthma	4.38e-05	0.0003	CcSEcCtD
Pomalidomide—Hyperhidrosis—Dexamethasone—asthma	4.32e-05	0.000297	CcSEcCtD
Pomalidomide—Hyperhidrosis—Betamethasone—asthma	4.32e-05	0.000297	CcSEcCtD
Pomalidomide—Feeling abnormal—Hydrocortisone—asthma	4.31e-05	0.000296	CcSEcCtD
Pomalidomide—Vertigo—Prednisone—asthma	4.29e-05	0.000294	CcSEcCtD
Pomalidomide—Fatigue—Triamcinolone—asthma	4.25e-05	0.000291	CcSEcCtD
Pomalidomide—Fatigue—Methylprednisolone—asthma	4.24e-05	0.000291	CcSEcCtD
Pomalidomide—Pain—Triamcinolone—asthma	4.22e-05	0.000289	CcSEcCtD
Pomalidomide—Body temperature increased—Hydrocortisone—asthma	4.14e-05	0.000284	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Dexamethasone—asthma	4.07e-05	0.000279	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Betamethasone—asthma	4.07e-05	0.000279	CcSEcCtD
Pomalidomide—Arthralgia—Prednisone—asthma	4.06e-05	0.000279	CcSEcCtD
Pomalidomide—Feeling abnormal—Triamcinolone—asthma	4.06e-05	0.000279	CcSEcCtD
Pomalidomide—Feeling abnormal—Methylprednisolone—asthma	4.05e-05	0.000278	CcSEcCtD
Pomalidomide—Anxiety—Prednisone—asthma	4.05e-05	0.000278	CcSEcCtD
Pomalidomide—Insomnia—Betamethasone—asthma	4.05e-05	0.000277	CcSEcCtD
Pomalidomide—Insomnia—Dexamethasone—asthma	4.05e-05	0.000277	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.03e-05	0.000277	CcSEcCtD
Pomalidomide—Hypersensitivity—Prednisolone—asthma	3.95e-05	0.000271	CcSEcCtD
Pomalidomide—Body temperature increased—Triamcinolone—asthma	3.9e-05	0.000267	CcSEcCtD
Pomalidomide—Decreased appetite—Betamethasone—asthma	3.89e-05	0.000267	CcSEcCtD
Pomalidomide—Decreased appetite—Dexamethasone—asthma	3.89e-05	0.000267	CcSEcCtD
Pomalidomide—Infection—Prednisone—asthma	3.87e-05	0.000265	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Dexamethasone—asthma	3.86e-05	0.000265	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Betamethasone—asthma	3.86e-05	0.000265	CcSEcCtD
Pomalidomide—Hypersensitivity—Hydrocortisone—asthma	3.86e-05	0.000265	CcSEcCtD
Pomalidomide—Fatigue—Betamethasone—asthma	3.86e-05	0.000264	CcSEcCtD
Pomalidomide—Fatigue—Dexamethasone—asthma	3.86e-05	0.000264	CcSEcCtD
Pomalidomide—Pain—Betamethasone—asthma	3.82e-05	0.000262	CcSEcCtD
Pomalidomide—Pain—Dexamethasone—asthma	3.82e-05	0.000262	CcSEcCtD
Pomalidomide—Nervous system disorder—Prednisone—asthma	3.82e-05	0.000262	CcSEcCtD
Pomalidomide—Skin disorder—Prednisone—asthma	3.78e-05	0.000259	CcSEcCtD
Pomalidomide—Hyperhidrosis—Prednisone—asthma	3.77e-05	0.000258	CcSEcCtD
Pomalidomide—Asthenia—Hydrocortisone—asthma	3.76e-05	0.000258	CcSEcCtD
Pomalidomide—Pruritus—Hydrocortisone—asthma	3.7e-05	0.000254	CcSEcCtD
Pomalidomide—Feeling abnormal—Dexamethasone—asthma	3.69e-05	0.000253	CcSEcCtD
Pomalidomide—Feeling abnormal—Betamethasone—asthma	3.69e-05	0.000253	CcSEcCtD
Pomalidomide—Hypersensitivity—Triamcinolone—asthma	3.63e-05	0.000249	CcSEcCtD
Pomalidomide—Hypersensitivity—Methylprednisolone—asthma	3.62e-05	0.000249	CcSEcCtD
Pomalidomide—Diarrhoea—Hydrocortisone—asthma	3.58e-05	0.000246	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Prednisone—asthma	3.55e-05	0.000243	CcSEcCtD
Pomalidomide—Dizziness—Prednisolone—asthma	3.54e-05	0.000243	CcSEcCtD
Pomalidomide—Asthenia—Triamcinolone—asthma	3.54e-05	0.000243	CcSEcCtD
Pomalidomide—Body temperature increased—Dexamethasone—asthma	3.54e-05	0.000242	CcSEcCtD
Pomalidomide—Body temperature increased—Betamethasone—asthma	3.54e-05	0.000242	CcSEcCtD
Pomalidomide—Asthenia—Methylprednisolone—asthma	3.53e-05	0.000242	CcSEcCtD
Pomalidomide—Insomnia—Prednisone—asthma	3.52e-05	0.000242	CcSEcCtD
Pomalidomide—Pruritus—Triamcinolone—asthma	3.49e-05	0.000239	CcSEcCtD
Pomalidomide—Pruritus—Methylprednisolone—asthma	3.48e-05	0.000239	CcSEcCtD
Pomalidomide—Dizziness—Hydrocortisone—asthma	3.46e-05	0.000237	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—BCL2—asthma	3.43e-05	0.000472	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—EGFR—asthma	3.4e-05	0.000467	CbGpPWpGaD
Pomalidomide—Decreased appetite—Prednisone—asthma	3.39e-05	0.000232	CcSEcCtD
Pomalidomide—Rash—Prednisolone—asthma	3.38e-05	0.000232	CcSEcCtD
Pomalidomide—Dermatitis—Prednisolone—asthma	3.38e-05	0.000232	CcSEcCtD
Pomalidomide—Diarrhoea—Methylprednisolone—asthma	3.36e-05	0.000231	CcSEcCtD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—asthma	3.36e-05	0.000462	CbGpPWpGaD
Pomalidomide—Fatigue—Prednisone—asthma	3.36e-05	0.00023	CcSEcCtD
Pomalidomide—Headache—Prednisolone—asthma	3.36e-05	0.00023	CcSEcCtD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—asthma	3.33e-05	0.000459	CbGpPWpGaD
Pomalidomide—Constipation—Prednisone—asthma	3.33e-05	0.000228	CcSEcCtD
Pomalidomide—Vomiting—Hydrocortisone—asthma	3.33e-05	0.000228	CcSEcCtD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—asthma	3.31e-05	0.000456	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—asthma	3.3e-05	0.000454	CbGpPWpGaD
Pomalidomide—Rash—Hydrocortisone—asthma	3.3e-05	0.000226	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—asthma	3.3e-05	0.000454	CbGpPWpGaD
Pomalidomide—Dermatitis—Hydrocortisone—asthma	3.3e-05	0.000226	CcSEcCtD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LTC4S—asthma	3.29e-05	0.000453	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	3.28e-05	0.000452	CbGpPWpGaD
Pomalidomide—Headache—Hydrocortisone—asthma	3.28e-05	0.000225	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—RHOA—asthma	3.27e-05	0.00045	CbGpPWpGaD
Pomalidomide—Dizziness—Triamcinolone—asthma	3.26e-05	0.000224	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	3.26e-05	0.000448	CbGpPWpGaD
Pomalidomide—Dizziness—Methylprednisolone—asthma	3.25e-05	0.000223	CcSEcCtD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	3.22e-05	0.000444	CbGpPWpGaD
Pomalidomide—Feeling abnormal—Prednisone—asthma	3.21e-05	0.00022	CcSEcCtD
Pomalidomide—Asthenia—Dexamethasone—asthma	3.21e-05	0.00022	CcSEcCtD
Pomalidomide—Asthenia—Betamethasone—asthma	3.21e-05	0.00022	CcSEcCtD
Pomalidomide—TNF—Adipogenesis—TGFB1—asthma	3.2e-05	0.000441	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—asthma	3.18e-05	0.000438	CbGpPWpGaD
Pomalidomide—Nausea—Prednisolone—asthma	3.18e-05	0.000218	CcSEcCtD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	3.17e-05	0.000436	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—asthma	3.17e-05	0.000436	CbGpPWpGaD
Pomalidomide—Pruritus—Dexamethasone—asthma	3.16e-05	0.000217	CcSEcCtD
Pomalidomide—Pruritus—Betamethasone—asthma	3.16e-05	0.000217	CcSEcCtD
Pomalidomide—Vomiting—Triamcinolone—asthma	3.13e-05	0.000215	CcSEcCtD
Pomalidomide—Vomiting—Methylprednisolone—asthma	3.13e-05	0.000214	CcSEcCtD
Pomalidomide—Nausea—Hydrocortisone—asthma	3.11e-05	0.000213	CcSEcCtD
Pomalidomide—Rash—Triamcinolone—asthma	3.11e-05	0.000213	CcSEcCtD
Pomalidomide—Dermatitis—Triamcinolone—asthma	3.1e-05	0.000213	CcSEcCtD
Pomalidomide—Rash—Methylprednisolone—asthma	3.1e-05	0.000213	CcSEcCtD
Pomalidomide—Dermatitis—Methylprednisolone—asthma	3.1e-05	0.000212	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—IFNG—asthma	3.09e-05	0.000425	CbGpPWpGaD
Pomalidomide—Headache—Triamcinolone—asthma	3.09e-05	0.000212	CcSEcCtD
Pomalidomide—Headache—Methylprednisolone—asthma	3.08e-05	0.000211	CcSEcCtD
Pomalidomide—Body temperature increased—Prednisone—asthma	3.08e-05	0.000211	CcSEcCtD
Pomalidomide—Diarrhoea—Betamethasone—asthma	3.06e-05	0.00021	CcSEcCtD
Pomalidomide—Diarrhoea—Dexamethasone—asthma	3.06e-05	0.00021	CcSEcCtD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CHAT—asthma	3.02e-05	0.000416	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IFNG—asthma	3.02e-05	0.000416	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—VEGFA—asthma	3.02e-05	0.000415	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—asthma	2.98e-05	0.000411	CbGpPWpGaD
Pomalidomide—Dizziness—Betamethasone—asthma	2.96e-05	0.000203	CcSEcCtD
Pomalidomide—Dizziness—Dexamethasone—asthma	2.96e-05	0.000203	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—asthma	2.93e-05	0.000404	CbGpPWpGaD
Pomalidomide—Nausea—Triamcinolone—asthma	2.93e-05	0.000201	CcSEcCtD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—asthma	2.93e-05	0.000403	CbGpPWpGaD
Pomalidomide—Nausea—Methylprednisolone—asthma	2.92e-05	0.0002	CcSEcCtD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	2.9e-05	0.000399	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL8—asthma	2.87e-05	0.000395	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Prednisone—asthma	2.87e-05	0.000197	CcSEcCtD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—asthma	2.85e-05	0.000393	CbGpPWpGaD
Pomalidomide—Vomiting—Betamethasone—asthma	2.84e-05	0.000195	CcSEcCtD
Pomalidomide—Vomiting—Dexamethasone—asthma	2.84e-05	0.000195	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.84e-05	0.000391	CbGpPWpGaD
Pomalidomide—Rash—Betamethasone—asthma	2.82e-05	0.000193	CcSEcCtD
Pomalidomide—Rash—Dexamethasone—asthma	2.82e-05	0.000193	CcSEcCtD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	2.82e-05	0.000388	CbGpPWpGaD
Pomalidomide—Dermatitis—Dexamethasone—asthma	2.82e-05	0.000193	CcSEcCtD
Pomalidomide—Dermatitis—Betamethasone—asthma	2.82e-05	0.000193	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—CXCL8—asthma	2.81e-05	0.000386	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—asthma	2.81e-05	0.000386	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ALDH2—asthma	2.8e-05	0.000386	CbGpPWpGaD
Pomalidomide—Headache—Betamethasone—asthma	2.8e-05	0.000192	CcSEcCtD
Pomalidomide—Headache—Dexamethasone—asthma	2.8e-05	0.000192	CcSEcCtD
Pomalidomide—Asthenia—Prednisone—asthma	2.79e-05	0.000192	CcSEcCtD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.79e-05	0.000383	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—asthma	2.76e-05	0.000379	CbGpPWpGaD
Pomalidomide—Pruritus—Prednisone—asthma	2.76e-05	0.000189	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—IL2—asthma	2.75e-05	0.000378	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.69e-05	0.000371	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—asthma	2.69e-05	0.000371	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2—asthma	2.68e-05	0.000369	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTT1—asthma	2.67e-05	0.000367	CbGpPWpGaD
Pomalidomide—Diarrhoea—Prednisone—asthma	2.66e-05	0.000183	CcSEcCtD
Pomalidomide—Nausea—Dexamethasone—asthma	2.66e-05	0.000182	CcSEcCtD
Pomalidomide—Nausea—Betamethasone—asthma	2.66e-05	0.000182	CcSEcCtD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	2.65e-05	0.000365	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	2.63e-05	0.000362	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TGFB1—asthma	2.61e-05	0.000359	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—asthma	2.61e-05	0.000359	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—SMAD3—asthma	2.6e-05	0.000358	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—MMP9—asthma	2.6e-05	0.000358	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LTC4S—asthma	2.59e-05	0.000357	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	2.58e-05	0.000355	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	2.58e-05	0.000355	CbGpPWpGaD
Pomalidomide—Dizziness—Prednisone—asthma	2.58e-05	0.000177	CcSEcCtD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—asthma	2.58e-05	0.000354	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CARM1—asthma	2.57e-05	0.000354	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.57e-05	0.000353	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—EGFR—asthma	2.56e-05	0.000352	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	2.53e-05	0.000349	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—asthma	2.53e-05	0.000348	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—asthma	2.52e-05	0.000347	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—asthma	2.52e-05	0.000347	CbGpPWpGaD
Pomalidomide—Vomiting—Prednisone—asthma	2.48e-05	0.00017	CcSEcCtD
Pomalidomide—Rash—Prednisone—asthma	2.46e-05	0.000168	CcSEcCtD
Pomalidomide—Dermatitis—Prednisone—asthma	2.45e-05	0.000168	CcSEcCtD
Pomalidomide—Headache—Prednisone—asthma	2.44e-05	0.000167	CcSEcCtD
Pomalidomide—TNF—Adipogenesis—IL6—asthma	2.41e-05	0.000332	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—asthma	2.4e-05	0.000331	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—asthma	2.4e-05	0.000331	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTP1—asthma	2.39e-05	0.000329	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTP1—asthma	2.36e-05	0.000325	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.36e-05	0.000324	CbGpPWpGaD
Pomalidomide—Nausea—Prednisone—asthma	2.31e-05	0.000159	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.31e-05	0.000318	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—asthma	2.29e-05	0.000315	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—VEGFA—asthma	2.28e-05	0.000314	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.26e-05	0.000311	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LTA4H—asthma	2.25e-05	0.000309	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LEP—asthma	2.22e-05	0.000306	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTM1—asthma	2.2e-05	0.000303	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTM1—asthma	2.17e-05	0.000299	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—asthma	2.14e-05	0.000295	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.12e-05	0.000292	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	2.11e-05	0.000291	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—EGFR—asthma	2.1e-05	0.000289	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—asthma	2.09e-05	0.000288	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—asthma	2.09e-05	0.000287	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—asthma	2.04e-05	0.000281	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—asthma	2e-05	0.000275	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ARG1—asthma	1.96e-05	0.00027	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—asthma	1.95e-05	0.000269	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6R—asthma	1.86e-05	0.000256	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTP1—asthma	1.85e-05	0.000254	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LTC4S—asthma	1.84e-05	0.000253	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.82e-05	0.000251	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.79e-05	0.000247	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.79e-05	0.000247	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALDH7A1—asthma	1.78e-05	0.000244	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	1.76e-05	0.000242	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	1.73e-05	0.000238	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—asthma	1.71e-05	0.000235	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ARG2—asthma	1.7e-05	0.000234	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTM1—asthma	1.7e-05	0.000234	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—RHOA—asthma	1.68e-05	0.000232	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.67e-05	0.00023	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—asthma	1.61e-05	0.000222	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LTA4H—asthma	1.59e-05	0.000219	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.59e-05	0.000218	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—asthma	1.55e-05	0.000214	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.52e-05	0.00021	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	1.5e-05	0.000207	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.49e-05	0.000205	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LTC4S—asthma	1.47e-05	0.000202	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.46e-05	0.0002	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—asthma	1.45e-05	0.0002	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.43e-05	0.000197	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	1.43e-05	0.000197	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALOX5AP—asthma	1.41e-05	0.000194	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALOX15—asthma	1.41e-05	0.000194	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ARG1—asthma	1.39e-05	0.000192	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.36e-05	0.000187	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—DCN—asthma	1.35e-05	0.000185	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CHAT—asthma	1.35e-05	0.000185	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP9—asthma	1.34e-05	0.000184	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	1.28e-05	0.000177	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LTA4H—asthma	1.27e-05	0.000175	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDH7A1—asthma	1.26e-05	0.000173	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	1.25e-05	0.000171	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ARG2—asthma	1.21e-05	0.000166	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—asthma	1.2e-05	0.000165	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—asthma	1.2e-05	0.000165	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALOX5—asthma	1.2e-05	0.000165	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—STAT3—asthma	1.19e-05	0.000164	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CARM1—asthma	1.14e-05	0.000157	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LTC4S—asthma	1.13e-05	0.000156	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DCN—asthma	1.13e-05	0.000155	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.13e-05	0.000155	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ARG1—asthma	1.11e-05	0.000153	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CYBA—asthma	1.11e-05	0.000153	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—asthma	1.1e-05	0.000152	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALDH2—asthma	1.1e-05	0.000151	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PARP1—asthma	1.09e-05	0.000149	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—EGFR—asthma	1.08e-05	0.000149	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.08e-05	0.000149	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—asthma	1.05e-05	0.000145	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTT1—asthma	1.04e-05	0.000144	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.03e-05	0.000142	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS1—asthma	1.02e-05	0.00014	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADCY2—asthma	1.01e-05	0.000139	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.01e-05	0.000139	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDH7A1—asthma	1e-05	0.000138	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALOX5AP—asthma	1e-05	0.000138	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALOX15—asthma	1e-05	0.000138	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LTA4H—asthma	9.81e-06	0.000135	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	9.64e-06	0.000133	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ARG2—asthma	9.64e-06	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	9.62e-06	0.000132	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CHAT—asthma	9.54e-06	0.000131	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NQO1—asthma	8.67e-06	0.000119	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ARG1—asthma	8.58e-06	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALOX5—asthma	8.5e-06	0.000117	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ITPR1—asthma	8.5e-06	0.000117	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADCY2—asthma	8.49e-06	0.000117	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	8.45e-06	0.000116	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—asthma	8.3e-06	0.000114	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CARM1—asthma	8.11e-06	0.000112	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD86—asthma	8.09e-06	0.000111	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DCN—asthma	8e-06	0.00011	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALOX5AP—asthma	7.98e-06	0.00011	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALOX15—asthma	7.98e-06	0.00011	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDH2—asthma	7.78e-06	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH7A1—asthma	7.76e-06	0.000107	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SMAD3—asthma	7.64e-06	0.000105	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CHAT—asthma	7.62e-06	0.000105	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ARG2—asthma	7.44e-06	0.000102	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—asthma	7.4e-06	0.000102	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	7.34e-06	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PPP2CA—asthma	7.31e-06	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—asthma	7.23e-06	9.95e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—asthma	7.18e-06	9.88e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—asthma	7.13e-06	9.82e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ITPR1—asthma	7.12e-06	9.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—asthma	7.04e-06	9.69e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PDGFB—asthma	6.83e-06	9.4e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALOX5—asthma	6.79e-06	9.34e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G4A—asthma	6.65e-06	9.15e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—asthma	6.65e-06	9.15e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—asthma	6.48e-06	8.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CARM1—asthma	6.48e-06	8.91e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DCN—asthma	6.38e-06	8.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDH2—asthma	6.21e-06	8.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALOX15—asthma	6.16e-06	8.48e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALOX5AP—asthma	6.16e-06	8.48e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NQO1—asthma	6.15e-06	8.46e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPP2CA—asthma	6.12e-06	8.42e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—asthma	6.09e-06	8.37e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADCY2—asthma	6.02e-06	8.28e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	5.97e-06	8.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—asthma	5.91e-06	8.13e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CHAT—asthma	5.88e-06	8.09e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6R—asthma	5.47e-06	7.53e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	5.44e-06	7.49e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALOX5—asthma	5.24e-06	7.21e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—asthma	5.13e-06	7.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—asthma	5.12e-06	7.05e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—asthma	5.06e-06	6.96e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ITPR1—asthma	5.05e-06	6.94e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CARM1—asthma	5e-06	6.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—asthma	4.99e-06	6.87e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RHOA—asthma	4.94e-06	6.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DCN—asthma	4.93e-06	6.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NQO1—asthma	4.91e-06	6.75e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—asthma	4.89e-06	6.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADCY2—asthma	4.8e-06	6.61e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH2—asthma	4.79e-06	6.59e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.76e-06	6.55e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G4A—asthma	4.71e-06	6.48e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—asthma	4.71e-06	6.48e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—asthma	4.7e-06	6.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—asthma	4.56e-06	6.27e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—asthma	4.51e-06	6.2e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPP2CA—asthma	4.34e-06	5.97e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—asthma	4.28e-06	5.89e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	4.15e-06	5.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—asthma	4.1e-06	5.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—asthma	4.09e-06	5.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—asthma	4.04e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ITPR1—asthma	4.03e-06	5.54e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—asthma	3.98e-06	5.48e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PTEN—asthma	3.9e-06	5.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NQO1—asthma	3.79e-06	5.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G4A—asthma	3.76e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—asthma	3.76e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADCY2—asthma	3.71e-06	5.1e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—asthma	3.49e-06	4.8e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPP2CA—asthma	3.46e-06	4.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—asthma	3.33e-06	4.58e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTEN—asthma	3.27e-06	4.5e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—asthma	3.24e-06	4.45e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGFR—asthma	3.17e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—asthma	3.16e-06	4.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—asthma	3.12e-06	4.29e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ITPR1—asthma	3.11e-06	4.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—asthma	3.07e-06	4.23e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—asthma	3.04e-06	4.18e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—asthma	2.9e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—asthma	2.9e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G4A—asthma	2.9e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPP2CA—asthma	2.67e-06	3.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—asthma	2.66e-06	3.66e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—asthma	2.66e-06	3.66e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—asthma	2.44e-06	3.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—asthma	2.42e-06	3.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—asthma	2.32e-06	3.19e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTEN—asthma	2.32e-06	3.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—asthma	2.12e-06	2.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—asthma	2.05e-06	2.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—asthma	1.87e-06	2.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTEN—asthma	1.85e-06	2.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—asthma	1.79e-06	2.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—asthma	1.64e-06	2.25e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTEN—asthma	1.43e-06	1.96e-05	CbGpPWpGaD
